{"id":351067,"date":"2025-08-25T20:21:20","date_gmt":"2025-08-25T20:21:20","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-corbus-pharmaceuticals-holdings\/"},"modified":"2025-08-25T20:21:20","modified_gmt":"2025-08-25T20:21:20","slug":"how-to-buy-corbus-pharmaceuticals-holdings","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334009,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-351067","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP), ph\u00e2n t\u00edch xu h\u01b0\u1edbng gi\u00e1 hi\u1ec7n t\u1ea1i v\u00e0 hi\u1ec3u c\u00e1c c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 trong c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed5i m\u1edbi n\u00e0y.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP), ph\u00e2n t\u00edch xu h\u01b0\u1edbng gi\u00e1 hi\u1ec7n t\u1ea1i v\u00e0 hi\u1ec3u c\u00e1c c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 trong c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed5i m\u1edbi n\u00e0y."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn? Corbus Pharmaceuticals (CRBP) \u0111\u1ea1i di\u1ec7n cho th\u1ebf gi\u1edbi h\u1ea5p d\u1eabn c\u1ee7a ph\u00e1t tri\u1ec3n thu\u1ed1c giai \u0111o\u1ea1n l\u00e2m s\u00e0ng, n\u01a1i nh\u1eefng kh\u00e1m ph\u00e1 y h\u1ecdc \u0111\u1ed9t ph\u00e1 c\u00f3 th\u1ec3 t\u1ea1o ra c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 phi th\u01b0\u1eddng. C\u00f4ng ty n\u00e0y \u0111\u1ee9ng \u1edf giao \u0111i\u1ec3m c\u1ee7a nghi\u00ean c\u1ee9u ung th\u01b0 v\u00e0 b\u1ec7nh chuy\u1ec3n h\u00f3a \u2014 hai l\u0129nh v\u1ef1c h\u1ee9a h\u1eb9n nh\u1ea5t trong ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng y h\u1ecdc ti\u1ec1m n\u0103ng n\u00e0y.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o \u0111\u1ed5i m\u1edbi c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn? Corbus Pharmaceuticals (CRBP) \u0111\u1ea1i di\u1ec7n cho th\u1ebf gi\u1edbi h\u1ea5p d\u1eabn c\u1ee7a ph\u00e1t tri\u1ec3n thu\u1ed1c giai \u0111o\u1ea1n l\u00e2m s\u00e0ng, n\u01a1i nh\u1eefng kh\u00e1m ph\u00e1 y h\u1ecdc \u0111\u1ed9t ph\u00e1 c\u00f3 th\u1ec3 t\u1ea1o ra c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 phi th\u01b0\u1eddng. C\u00f4ng ty n\u00e0y \u0111\u1ee9ng \u1edf giao \u0111i\u1ec3m c\u1ee7a nghi\u00ean c\u1ee9u ung th\u01b0 v\u00e0 b\u1ec7nh chuy\u1ec3n h\u00f3a \u2014 hai l\u0129nh v\u1ef1c h\u1ee9a h\u1eb9n nh\u1ea5t trong ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 c\u00e1ch b\u1ea1n c\u00f3 th\u1ec3 s\u1edf h\u1eefu m\u1ed9t ph\u1ea7n c\u1ee7a cu\u1ed9c c\u00e1ch m\u1ea1ng y h\u1ecdc ti\u1ec1m n\u0103ng n\u00e0y."},"body_html":"<h2>\ud83d\udcc8 Ph\u00e2n T\u00edch C\u1ed5 Phi\u1ebfu CRBP: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Corbus Pharmaceuticals Holdings, Inc. (CRBP) giao d\u1ecbch \u1edf m\u1ee9c <strong>9,22 USD<\/strong> \u2014 m\u1ed9t th\u1eddi \u0111i\u1ec3m quan tr\u1ecdng \u0111\u1ed1i v\u1edbi c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng n\u00e0y. C\u1ed5 phi\u1ebfu \u0111\u00e3 tr\u1ea3i qua nhi\u1ec1u bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh, nh\u01b0ng m\u1ee9c gi\u00e1 hi\u1ec7n t\u1ea1i mang l\u1ea1i c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 th\u00f4ng minh.<\/p> <p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Th\u00e1ng 11 n\u0103m 2025 l\u00e0 th\u1eddi \u0111i\u1ec3m c\u1ef1c k\u1ef3 quan tr\u1ecdng!<\/strong> \u0110\u00f3 l\u00e0 khi CRBP d\u1ef1 ki\u1ebfn s\u1ebd c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp ti\u1ebfp theo, v\u00e0 theo l\u1ecbch s\u1eed, nh\u1eefng th\u1eddi \u0111i\u1ec3m n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn trong c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p> <h3>C\u00e1ch K\u1ebft Qu\u1ea3 Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu CRBP<\/h3> <p>Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc s\u1ed1ng v\u00e0 ch\u1ebft d\u1ef1a v\u00e0o k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng. \u0110\u1ed1i v\u1edbi CRBP, m\u00f4 h\u00ecnh r\u1ea5t r\u00f5 r\u00e0ng: d\u1eef li\u1ec7u t\u00edch c\u1ef1c t\u1ea1o ra s\u1ef1 t\u0103ng gi\u00e1 b\u00f9ng n\u1ed5, trong khi k\u1ebft qu\u1ea3 th\u1ea5t v\u1ecdng k\u00edch ho\u1ea1t c\u00e1c \u0111\u1ee3t b\u00e1n th\u00e1o nghi\u00eam tr\u1ecdng. S\u1ef1 \u1ed5n \u0111\u1ecbnh t\u00e0i ch\u00ednh g\u1ea7n \u0111\u00e2y c\u1ee7a c\u00f4ng ty \u2014 <a href=\"https:\/\/ir.corbuspharma.com\/news-events\/press-releases\/detail\/447\/corbus-pharmaceuticals-reports-second-quarter-2025-financial-results-and-provides-a-corporate-update\">v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 116,6 tri\u1ec7u USD<\/a> t\u00ednh \u0111\u1ebfn qu\u00fd 2 n\u0103m 2025 \u2014 cung c\u1ea5p ngu\u1ed3n l\u1ef1c quan tr\u1ecdng \u0111\u1ec3 v\u01b0\u1ee3t qua c\u00e1c giai \u0111o\u1ea1n \u0111\u1ecdc d\u1eef li\u1ec7u then ch\u1ed1t.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u1eeb Tuy\u1ec7t V\u1ecdng \u0110\u1ebfn Hy V\u1ecdng<\/h2> <p>CRBP \u0111\u00e3 tr\u1ea3i qua s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ef1c \u0111oan trong s\u00e1u th\u00e1ng qua, minh h\u1ecda ho\u00e0n h\u1ea3o cho b\u1ea3n ch\u1ea5t r\u1ee7i ro cao, ph\u1ea7n th\u01b0\u1edfng cao c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc:<\/p> <table> <thead> <tr><th>Th\u00e1ng<\/th><th>Kho\u1ea3ng Gi\u00e1<\/th><th>Ch\u1ea5t X\u00fac T\u00e1c Ch\u00ednh<\/th><\/tr> <\/thead> <tbody> <tr><td>Th\u00e1ng 3 n\u0103m 2025<\/td><td>4,50-6,20 USD<\/td><td>B\u1ea5t \u1ed5n th\u1ecb tr\u01b0\u1eddng, lu\u00e2n chuy\u1ec3n ng\u00e0nh<\/td><\/tr> <tr><td>Th\u00e1ng 4 n\u0103m 2025<\/td><td>5,80-7,40 USD<\/td><td>L\u1ea1c quan d\u1eef li\u1ec7u s\u1edbm CRB-701<\/td><\/tr> <tr><td>Th\u00e1ng 5 n\u0103m 2025<\/td><td>6,90-8,70 USD<\/td><td>S\u1ef1 ch\u00fa \u00fd t\u1eeb bu\u1ed5i thuy\u1ebft tr\u00ecnh c\u1ee7a RBC Capital Markets<\/td><\/tr> <tr><td>Th\u00e1ng 6 n\u0103m 2025<\/td><td>7,20-9,10 USD<\/td><td>B\u1eaft \u0111\u1ea7u giai \u0111o\u1ea1n 1 CRB-913<\/td><\/tr> <tr><td>Th\u00e1ng 7 n\u0103m 2025<\/td><td>8,50-10,80 USD<\/td><td>K\u1ebft qu\u1ea3 qu\u00fd 2 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng<\/td><\/tr> <tr><td>Th\u00e1ng 8 n\u0103m 2025<\/td><td>8,80-11,20 USD<\/td><td>Chu\u1ea9n b\u1ecb cho ESMO 2025<\/td><\/tr> <\/tbody> <\/table> <p><strong>Xu h\u01b0\u1edbng t\u1ed5ng th\u1ec3<\/strong>: Ph\u1ee5c h\u1ed3i +104% t\u1eeb m\u1ee9c th\u1ea5p th\u00e1ng 3, th\u1ec3 hi\u1ec7n ti\u1ec1m n\u0103ng ph\u1ee5c h\u1ed3i \u0111\u00e1ng kinh ng\u1ea1c trong c\u00e1c cu\u1ed9c chuy\u1ec3n m\u00ecnh th\u00e0nh c\u00f4ng c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p> <p>Bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh c\u1ee7a c\u1ed5 phi\u1ebfu ph\u1ea3n \u00e1nh t\u00ednh nh\u1ecb ph\u00e2n c\u1ee7a k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng \u2014 m\u1ed7i l\u1ea7n \u0111\u1ecdc d\u1eef li\u1ec7u l\u00e0 m\u1ed9t s\u1ef1 ki\u1ec7n c\u00f3 th\u1ec3 l\u00e0m n\u00ean ho\u1eb7c ph\u00e1 v\u1ee1 c\u00f4ng ty.<\/p> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p>D\u1ef1a tr\u00ean ti\u1ebfn tr\u00ecnh l\u00e2m s\u00e0ng hi\u1ec7n t\u1ea1i v\u00e0 d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 mang l\u1ea1i:<\/p> <p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: Kho\u1ea3ng 18-25 USD (t\u0103ng 95-171%)<\/p> <ul> <li>Ch\u1ea5t x\u00fac t\u00e1c: \u0110\u1ecdc d\u1eef li\u1ec7u ESMO, ho\u00e0n th\u00e0nh giai \u0111o\u1ea1n 1 CRB-913<\/li> <li><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro<\/li> <\/ul> <p><strong>D\u1ef1 b\u00e1o 2026<\/strong>: Kho\u1ea3ng 30-45 USD<\/p> <ul> <li>C\u00f3 th\u1ec3 m\u1edf r\u1ed9ng c\u00e1c ch\u1ec9 \u0111\u1ecbnh FDA Fast Track<\/li> <li>C\u01a1 h\u1ed9i h\u1ee3p t\u00e1c \u0111ang h\u00ecnh th\u00e0nh<\/li> <\/ul> <p><strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: Kho\u1ea3ng 60-85 USD<\/p> <ul> <li>C\u00f3 th\u1ec3 ra m\u1eaft s\u1ea3n ph\u1ea9m th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean<\/li> <li>D\u00f2ng doanh thu \u1ed5n \u0111\u1ecbnh t\u1eeb c\u00e1c h\u1ee3p t\u00e1c<\/li> <\/ul> <p><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: Ti\u1ec1m n\u0103ng tr\u00ean 100 USD<\/p> <ul> <li>Nhi\u1ec1u li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t<\/li> <li>\u0110\u1ea1t l\u1ee3i nhu\u1eadn b\u1ec1n v\u1eefng<\/li> <\/ul> <p>Nh\u1eefng d\u1ef1 b\u00e1o n\u00e0y gi\u1ea3 \u0111\u1ecbnh k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng th\u00e0nh c\u00f4ng \u2014 y\u1ebfu t\u1ed1 r\u1ee7i ro c\u01a1 b\u1ea3n m\u00e0 m\u1ecdi nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ph\u1ea3i th\u1eeba nh\u1eadn.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><strong>R\u1ee7i Ro Th\u1ea5t B\u1ea1i L\u00e2m S\u00e0ng<\/strong>: Ch\u1ec9 kho\u1ea3ng 6% \u1ee9ng vi\u00ean thu\u1ed1c cu\u1ed1i c\u00f9ng \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t<\/li> <li><strong>Lo Ng\u1ea1i V\u1ec1 Ti\u00eau Hao Ti\u1ec1n M\u1eb7t<\/strong>: L\u1ed7 17 tri\u1ec7u USD m\u1ed7i qu\u00fd m\u1eb7c d\u00f9 c\u00f3 v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t m\u1ea1nh<\/li> <li><strong>\u00c1p L\u1ef1c C\u1ea1nh Tranh<\/strong>: Th\u1ecb tr\u01b0\u1eddng ADC v\u00e0 b\u00e9o ph\u00ec \u0111\u00f4ng \u0111\u00fac<\/li> <li><strong>Kh\u00f4ng Ch\u1eafc Ch\u1eafn V\u1ec1 Quy \u0110\u1ecbnh<\/strong>: Quy tr\u00ecnh ph\u00ea duy\u1ec7t FDA kh\u00f3 \u0111o\u00e1n<\/li> <li><strong>R\u1ee7i Ro Pha Lo\u00e3ng<\/strong>: G\u00e2y qu\u1ef9 trong t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 l\u00e0m pha lo\u00e3ng c\u1ed5 \u0111\u00f4ng hi\u1ec7n h\u1eefu<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u Xanh Cho N\u0103m 2025<\/h3> <ul> <li><strong>\u0110\u01b0\u1eddng Ch\u1ea1y Ti\u1ec1n M\u1eb7t V\u1eefng V\u00e0ng<\/strong>: 116,6 tri\u1ec7u USD t\u00e0i tr\u1ee3 ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn n\u0103m 2027<\/li> <li><strong>Nhi\u1ec1u Ch\u1ea5t X\u00fac T\u00e1c<\/strong>: Ba ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng c\u00f3 d\u1eef li\u1ec7u \u0111\u1ecdc trong n\u0103m 2025<\/li> <li><strong>FDA Fast Track<\/strong>: CRB-701 \u0111\u00e3 c\u00f3 ch\u1ec9 \u0111\u1ecbnh cho ung th\u01b0 c\u1ed5 t\u1eed cung<\/li> <li><strong>Th\u1eddi \u0110i\u1ec3m Th\u1ecb Tr\u01b0\u1eddng<\/strong>: B\u00e9o ph\u00ec v\u00e0 ung th\u01b0 l\u00e0 c\u00e1c l\u0129nh v\u1ef1c n\u00f3ng nh\u1ea5t trong ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe<\/li> <li><strong>L\u00e3nh \u0110\u1ea1o Kinh Nghi\u1ec7m<\/strong>: CEO Yuval Cohen c\u00f3 th\u00e0nh t\u00edch m\u1ea1nh trong ng\u00e0nh<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-5% danh m\u1ee5c cho c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>Trung B\u00ecnh Gi\u00e1 \u0110\u00f4 La<\/strong>: X\u00e2y d\u1ef1ng v\u1ecb th\u1ebf d\u1ea7n d\u1ea7n tr\u01b0\u1edbc b\u00e1o c\u00e1o thu nh\u1eadp th\u00e1ng 11<\/li> <li><strong>\u0110\u1eb7t L\u1ec7nh C\u1eaft L\u1ed7<\/strong>: B\u1ea3o v\u1ec7 kh\u1ecfi th\u1ea5t b\u1ea1i th\u1ea3m kh\u1ed1c trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li> <li><strong>Theo D\u00f5i C\u00e1c Ch\u1ea5t X\u00fac T\u00e1c<\/strong>: \u0110\u00e1nh d\u1ea5u l\u1ecbch cho ESMO 2025 (th\u00e1ng 10) v\u00e0 b\u00e1o c\u00e1o qu\u00fd 3 (th\u00e1ng 11)<\/li> <\/ol> <p><strong>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc c\u1ee7a ng\u01b0\u1eddi k\u1ef3 c\u1ef1u<\/strong>: \"Giao d\u1ecbch CRBP gi\u1ed1ng nh\u01b0 xem phim y h\u1ecdc \u2014 99% l\u00e0 c\u00f4ng vi\u1ec7c ph\u00f2ng th\u00ed nghi\u1ec7m nh\u00e0m ch\u00e1n, 1% l\u00e0 nh\u1eefng kho\u1ea3nh kh\u1eafc ngh\u1eb9t th\u1edf quy\u1ebft \u0111\u1ecbnh t\u1ea5t c\u1ea3. Ch\u1ec9 c\u1ea7n \u0111\u1eebng qu\u00ean m\u00e1y kh\u1eed rung c\u1ea3m x\u00fac c\u1ee7a b\u1ea1n!\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o c\u00f3 truy c\u1eadp NASDAQ v\u00e0 ph\u00ed h\u1ee3p l\u00fd<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n Th\u00e0nh N\u1ea1p Ti\u1ec1n T\u00e0i Kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i c\u00f3 th\u1ec3 m\u1ea5t<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm \"CRBP\"<\/td><td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n ch\u00ednh x\u00e1c c\u1ee7a Corbus Pharmaceuticals<\/td><\/tr> <tr><td>4<\/td><td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td><td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o trong c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng<\/td><\/tr> <tr><td>5<\/td><td>Xem L\u1ea1i v\u00e0 X\u00e1c Nh\u1eadn<\/td><td>Ki\u1ec3m tra k\u1ef9 chi ti\u1ebft l\u1ec7nh tr\u01b0\u1edbc khi ho\u00e0n t\u1ea5t<\/td><\/tr> <tr><td>6<\/td><td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td><td>Theo d\u00f5i c\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3\/kh\u00e1ng c\u1ef1 quan tr\u1ecdng<\/td><\/tr> <tr><td>7<\/td><td>L\u1eadp K\u1ebf Ho\u1ea1ch R\u00fat L\u1eddi<\/td><td>X\u00e1c \u0111\u1ecbnh tr\u01b0\u1edbc c\u00e1c m\u1ee9c ch\u1ed1t l\u1eddi v\u00e0 c\u1eaft l\u1ed7<\/td><\/tr> <tr><td>8<\/td><td>Ghi L\u1ea1i L\u00fd Do \u0110\u1ea7u T\u01b0<\/td><td>Vi\u1ebft ra l\u00fd do \u0111\u1ea7u t\u01b0 \u0111\u1ec3 tr\u00e1nh quy\u1ebft \u0111\u1ecbnh theo c\u1ea3m x\u00fac<\/td><\/tr> <tr><td>9<\/td><td>Theo D\u00f5i Tin T\u1ee9c C\u00f4ng Ty<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o Google cho c\u00e1c c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng c\u1ee7a CRBP<\/td><\/tr> <tr><td>10<\/td><td>\u0110\u00e1nh Gi\u00e1 \u0110\u1ecbnh K\u1ef3<\/td><td>\u0110\u00e1nh gi\u00e1 l\u1ea1i kho\u1ea3n \u0111\u1ea7u t\u01b0 sau m\u1ed7i b\u00e1o c\u00e1o thu nh\u1eadp<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option N\u1ed5i B\u1eadt Trong \u0110\u1ea7u T\u01b0 C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2> <p>Pocket Option c\u00e1ch m\u1ea1ng h\u00f3a giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1edbi c\u00e1c t\u00ednh n\u0103ng ph\u00f9 h\u1ee3p ho\u00e0n h\u1ea3o cho c\u00e1c c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng nh\u01b0 CRBP:<\/p> <ul> <li><strong>S\u1ed1 Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u Ch\u1ec9 5 USD<\/strong> - Th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi ti\u1ec1n th\u1eadt m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn<\/li> <li><strong>Th\u1ef1c Thi Nhanh Nh\u01b0 Ch\u1edbp<\/strong> - Quan tr\u1ecdng \u0111\u1ec3 b\u1eaft k\u1ecbp c\u00e1c bi\u1ebfn \u0111\u1ed9ng do tin t\u1ee9c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <li><strong>C\u00f4ng C\u1ee5 Bi\u1ec3u \u0110\u1ed3 Ti\u00ean Ti\u1ebfn<\/strong> - Ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt \u0111\u1ec3 \u0111\u1ecbnh th\u1eddi \u0111i\u1ec3m v\u00e0o l\u1ec7nh quanh c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng<\/li> <li><strong>Truy C\u1eadp Th\u1ecb Tr\u01b0\u1eddng To\u00e0n C\u1ea7u<\/strong> - Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc M\u1ef9 t\u1eeb b\u1ea5t c\u1ee9 \u0111\u00e2u tr\u00ean th\u1ebf gi\u1edbi<\/li> <li><strong>T\u00e0i Nguy\u00ean Gi\u00e1o D\u1ee5c<\/strong> - H\u1ecdc \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc qua <a href=\"\/blog\">blog Pocket Option<\/a><\/li> <\/ul> <p>Giao di\u1ec7n th\u00e2n thi\u1ec7n c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap ph\u00e2n t\u00edch c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ph\u1ee9c t\u1ea1p tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn v\u1edbi ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u \u0111\u1ed3ng th\u1eddi cung c\u1ea5p c\u00f4ng c\u1ee5 n\u00e2ng cao cho nh\u00e0 giao d\u1ecbch c\u00f3 kinh nghi\u1ec7m.<\/p> <h2>\ud83c\udf0d Corbus N\u0103m 2025: \u0110\u1ed5i M\u1edbi Ung Th\u01b0 G\u1eb7p G\u1ee1 Khoa H\u1ecdc Chuy\u1ec3n H\u00f3a<\/h2> <p>Corbus Pharmaceuticals \u0111\u1ee9ng \u1edf tuy\u1ebfn \u0111\u1ea7u \u0111\u1ed5i m\u1edbi y h\u1ecdc v\u1edbi ba ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng \u0111\u1ed9t ph\u00e1:<\/p> <ul> <li><strong>CRB-701<\/strong> - Li\u00ean h\u1ee3p kh\u00e1ng th\u1ec3 - thu\u1ed1c nh\u1eafm m\u1ee5c ti\u00eau Nectin-4 cho th\u1ea5y k\u1ebft qu\u1ea3 s\u1edbm \u0111\u1ea7y h\u1ee9a h\u1eb9n trong c\u00e1c kh\u1ed1i u r\u1eafn. <a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/05\/3127283\/0\/en\/Corbus-Pharmaceuticals-Reports-Second-Quarter-2025-Financial-Results-and-Provides-a-Corporate-Update.html\">Ch\u1ec9 \u0111\u1ecbnh FDA Fast Track<\/a> cho \u0111i\u1ec1u tr\u1ecb ung th\u01b0 c\u1ed5 t\u1eed cung nh\u1ea5n m\u1ea1nh ti\u1ec1m n\u0103ng c\u1ee7a n\u00f3.<\/li> <li><strong>CRB-913<\/strong> - Ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb b\u00e9o ph\u00ec th\u1ebf h\u1ec7 th\u1ee9 hai m\u1edbi tr\u00e1nh c\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 th\u1ea7n kinh \u0111\u00e3 l\u00e0m th\u1ea5t b\u1ea1i c\u00e1c ch\u1ea5t \u1ee9c ch\u1ebf CB1 tr\u01b0\u1edbc \u0111\u00f3. Nghi\u00ean c\u1ee9u giai \u0111o\u1ea1n 1 \u0111\u00e3 b\u1eaft \u0111\u1ea7u c\u00f3 th\u1ec3 khai th\u00e1c th\u1ecb tr\u01b0\u1eddng b\u00e9o ph\u00ec tr\u1ecb gi\u00e1 h\u01a1n 100 t\u1ef7 USD.<\/li> <li><strong>CRB-601<\/strong> - Li\u1ec7u ph\u00e1p ch\u1ed1ng integrin nh\u1eafm v\u00e0o nhi\u1ec1u lo\u1ea1i kh\u1ed1i u r\u1eafn, \u0111\u1ea1i di\u1ec7n cho c\u01a1 h\u1ed9i l\u00e2m s\u00e0ng l\u1edbn th\u1ee9 ba c\u1ee7a c\u00f4ng ty.<\/li> <\/ul> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: N\u0103m 2025, Corbus tr\u1edf th\u00e0nh m\u1ed9t trong s\u1ed1 \u00edt c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed3ng th\u1eddi ti\u1ebfn h\u00e0nh ba ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng ri\u00eang bi\u1ec7t trong khi duy tr\u00ec ngu\u1ed3n ti\u1ec1n m\u1eb7t \u0111\u1ee7 d\u00f9ng \u0111\u1ebfn n\u0103m 2027 \u2014 m\u1ed9t th\u00e0nh t\u1ef1u \u0111\u00e1ng kinh ng\u1ea1c v\u1ec1 hi\u1ec7u qu\u1ea3 v\u1ed1n trong ng\u00e0nh d\u01b0\u1ee3c sinh h\u1ecdc v\u1ed1n ti\u00eau hao ti\u1ec1n m\u1eb7t r\u1ea5t l\u1edbn.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Ph\u00e2n T\u00edch C\u1ed5 Phi\u1ebfu CRBP: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 V\u1ecb Th\u1ebf Th\u1ecb Tr\u01b0\u1eddng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 25 th\u00e1ng 8 n\u0103m 2025, Corbus Pharmaceuticals Holdings, Inc. (CRBP) giao d\u1ecbch \u1edf m\u1ee9c <strong>9,22 USD<\/strong> \u2014 m\u1ed9t th\u1eddi \u0111i\u1ec3m quan tr\u1ecdng \u0111\u1ed1i v\u1edbi c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng n\u00e0y. C\u1ed5 phi\u1ebfu \u0111\u00e3 tr\u1ea3i qua nhi\u1ec1u bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh, nh\u01b0ng m\u1ee9c gi\u00e1 hi\u1ec7n t\u1ea1i mang l\u1ea1i c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 th\u00f4ng minh.<\/p>\n<p><strong>\u0110\u00e1nh d\u1ea5u l\u1ecbch c\u1ee7a b\u1ea1n: Th\u00e1ng 11 n\u0103m 2025 l\u00e0 th\u1eddi \u0111i\u1ec3m c\u1ef1c k\u1ef3 quan tr\u1ecdng!<\/strong> \u0110\u00f3 l\u00e0 khi CRBP d\u1ef1 ki\u1ebfn s\u1ebd c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp ti\u1ebfp theo, v\u00e0 theo l\u1ecbch s\u1eed, nh\u1eefng th\u1eddi \u0111i\u1ec3m n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 l\u1edbn trong c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>\n<h3>C\u00e1ch K\u1ebft Qu\u1ea3 Th\u1eed Nghi\u1ec7m L\u00e2m S\u00e0ng \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu CRBP<\/h3>\n<p>Ng\u00e0nh c\u00f4ng ngh\u1ec7 sinh h\u1ecdc s\u1ed1ng v\u00e0 ch\u1ebft d\u1ef1a v\u00e0o k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng. \u0110\u1ed1i v\u1edbi CRBP, m\u00f4 h\u00ecnh r\u1ea5t r\u00f5 r\u00e0ng: d\u1eef li\u1ec7u t\u00edch c\u1ef1c t\u1ea1o ra s\u1ef1 t\u0103ng gi\u00e1 b\u00f9ng n\u1ed5, trong khi k\u1ebft qu\u1ea3 th\u1ea5t v\u1ecdng k\u00edch ho\u1ea1t c\u00e1c \u0111\u1ee3t b\u00e1n th\u00e1o nghi\u00eam tr\u1ecdng. S\u1ef1 \u1ed5n \u0111\u1ecbnh t\u00e0i ch\u00ednh g\u1ea7n \u0111\u00e2y c\u1ee7a c\u00f4ng ty \u2014 <a href=\"https:\/\/ir.corbuspharma.com\/news-events\/press-releases\/detail\/447\/corbus-pharmaceuticals-reports-second-quarter-2025-financial-results-and-provides-a-corporate-update\">v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t 116,6 tri\u1ec7u USD<\/a> t\u00ednh \u0111\u1ebfn qu\u00fd 2 n\u0103m 2025 \u2014 cung c\u1ea5p ngu\u1ed3n l\u1ef1c quan tr\u1ecdng \u0111\u1ec3 v\u01b0\u1ee3t qua c\u00e1c giai \u0111o\u1ea1n \u0111\u1ecdc d\u1eef li\u1ec7u then ch\u1ed1t.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng: T\u1eeb Tuy\u1ec7t V\u1ecdng \u0110\u1ebfn Hy V\u1ecdng<\/h2>\n<p>CRBP \u0111\u00e3 tr\u1ea3i qua s\u1ef1 bi\u1ebfn \u0111\u1ed9ng c\u1ef1c \u0111oan trong s\u00e1u th\u00e1ng qua, minh h\u1ecda ho\u00e0n h\u1ea3o cho b\u1ea3n ch\u1ea5t r\u1ee7i ro cao, ph\u1ea7n th\u01b0\u1edfng cao c\u1ee7a \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc:<\/p>\n<table>\n<thead>\n<tr>\n<th>Th\u00e1ng<\/th>\n<th>Kho\u1ea3ng Gi\u00e1<\/th>\n<th>Ch\u1ea5t X\u00fac T\u00e1c Ch\u00ednh<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Th\u00e1ng 3 n\u0103m 2025<\/td>\n<td>4,50-6,20 USD<\/td>\n<td>B\u1ea5t \u1ed5n th\u1ecb tr\u01b0\u1eddng, lu\u00e2n chuy\u1ec3n ng\u00e0nh<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 4 n\u0103m 2025<\/td>\n<td>5,80-7,40 USD<\/td>\n<td>L\u1ea1c quan d\u1eef li\u1ec7u s\u1edbm CRB-701<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 5 n\u0103m 2025<\/td>\n<td>6,90-8,70 USD<\/td>\n<td>S\u1ef1 ch\u00fa \u00fd t\u1eeb bu\u1ed5i thuy\u1ebft tr\u00ecnh c\u1ee7a RBC Capital Markets<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 6 n\u0103m 2025<\/td>\n<td>7,20-9,10 USD<\/td>\n<td>B\u1eaft \u0111\u1ea7u giai \u0111o\u1ea1n 1 CRB-913<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 7 n\u0103m 2025<\/td>\n<td>8,50-10,80 USD<\/td>\n<td>K\u1ebft qu\u1ea3 qu\u00fd 2 v\u01b0\u1ee3t k\u1ef3 v\u1ecdng<\/td>\n<\/tr>\n<tr>\n<td>Th\u00e1ng 8 n\u0103m 2025<\/td>\n<td>8,80-11,20 USD<\/td>\n<td>Chu\u1ea9n b\u1ecb cho ESMO 2025<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Xu h\u01b0\u1edbng t\u1ed5ng th\u1ec3<\/strong>: Ph\u1ee5c h\u1ed3i +104% t\u1eeb m\u1ee9c th\u1ea5p th\u00e1ng 3, th\u1ec3 hi\u1ec7n ti\u1ec1m n\u0103ng ph\u1ee5c h\u1ed3i \u0111\u00e1ng kinh ng\u1ea1c trong c\u00e1c cu\u1ed9c chuy\u1ec3n m\u00ecnh th\u00e0nh c\u00f4ng c\u1ee7a c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>\n<p>Bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh c\u1ee7a c\u1ed5 phi\u1ebfu ph\u1ea3n \u00e1nh t\u00ednh nh\u1ecb ph\u00e2n c\u1ee7a k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng \u2014 m\u1ed7i l\u1ea7n \u0111\u1ecdc d\u1eef li\u1ec7u l\u00e0 m\u1ed9t s\u1ef1 ki\u1ec7n c\u00f3 th\u1ec3 l\u00e0m n\u00ean ho\u1eb7c ph\u00e1 v\u1ee1 c\u00f4ng ty.<\/p>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p>D\u1ef1a tr\u00ean ti\u1ebfn tr\u00ecnh l\u00e2m s\u00e0ng hi\u1ec7n t\u1ea1i v\u00e0 d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c nh\u00e0 ph\u00e2n t\u00edch, \u0111\u00e2y l\u00e0 nh\u1eefng g\u00ec t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 mang l\u1ea1i:<\/p>\n<p><strong>Cu\u1ed1i n\u0103m 2025<\/strong>: Kho\u1ea3ng 18-25 USD (t\u0103ng 95-171%)<\/p>\n<ul>\n<li>Ch\u1ea5t x\u00fac t\u00e1c: \u0110\u1ecdc d\u1eef li\u1ec7u ESMO, ho\u00e0n th\u00e0nh giai \u0111o\u1ea1n 1 CRB-913<\/li>\n<li><strong>K\u1ebft lu\u1eadn<\/strong>: MUA M\u1ea0NH cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ecbu r\u1ee7i ro<\/li>\n<\/ul>\n<p><strong>D\u1ef1 b\u00e1o 2026<\/strong>: Kho\u1ea3ng 30-45 USD<\/p>\n<ul>\n<li>C\u00f3 th\u1ec3 m\u1edf r\u1ed9ng c\u00e1c ch\u1ec9 \u0111\u1ecbnh FDA Fast Track<\/li>\n<li>C\u01a1 h\u1ed9i h\u1ee3p t\u00e1c \u0111ang h\u00ecnh th\u00e0nh<\/li>\n<\/ul>\n<p><strong>Tri\u1ec3n v\u1ecdng 2028<\/strong>: Kho\u1ea3ng 60-85 USD<\/p>\n<ul>\n<li>C\u00f3 th\u1ec3 ra m\u1eaft s\u1ea3n ph\u1ea9m th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean<\/li>\n<li>D\u00f2ng doanh thu \u1ed5n \u0111\u1ecbnh t\u1eeb c\u00e1c h\u1ee3p t\u00e1c<\/li>\n<\/ul>\n<p><strong>T\u1ea7m nh\u00ecn 2030<\/strong>: Ti\u1ec1m n\u0103ng tr\u00ean 100 USD<\/p>\n<ul>\n<li>Nhi\u1ec1u li\u1ec7u ph\u00e1p \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t<\/li>\n<li>\u0110\u1ea1t l\u1ee3i nhu\u1eadn b\u1ec1n v\u1eefng<\/li>\n<\/ul>\n<p>Nh\u1eefng d\u1ef1 b\u00e1o n\u00e0y gi\u1ea3 \u0111\u1ecbnh k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng th\u00e0nh c\u00f4ng \u2014 y\u1ebfu t\u1ed1 r\u1ee7i ro c\u01a1 b\u1ea3n m\u00e0 m\u1ecdi nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ph\u1ea3i th\u1eeba nh\u1eadn.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><strong>R\u1ee7i Ro Th\u1ea5t B\u1ea1i L\u00e2m S\u00e0ng<\/strong>: Ch\u1ec9 kho\u1ea3ng 6% \u1ee9ng vi\u00ean thu\u1ed1c cu\u1ed1i c\u00f9ng \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t<\/li>\n<li><strong>Lo Ng\u1ea1i V\u1ec1 Ti\u00eau Hao Ti\u1ec1n M\u1eb7t<\/strong>: L\u1ed7 17 tri\u1ec7u USD m\u1ed7i qu\u00fd m\u1eb7c d\u00f9 c\u00f3 v\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t m\u1ea1nh<\/li>\n<li><strong>\u00c1p L\u1ef1c C\u1ea1nh Tranh<\/strong>: Th\u1ecb tr\u01b0\u1eddng ADC v\u00e0 b\u00e9o ph\u00ec \u0111\u00f4ng \u0111\u00fac<\/li>\n<li><strong>Kh\u00f4ng Ch\u1eafc Ch\u1eafn V\u1ec1 Quy \u0110\u1ecbnh<\/strong>: Quy tr\u00ecnh ph\u00ea duy\u1ec7t FDA kh\u00f3 \u0111o\u00e1n<\/li>\n<li><strong>R\u1ee7i Ro Pha Lo\u00e3ng<\/strong>: G\u00e2y qu\u1ef9 trong t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 l\u00e0m pha lo\u00e3ng c\u1ed5 \u0111\u00f4ng hi\u1ec7n h\u1eefu<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u Xanh Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>\u0110\u01b0\u1eddng Ch\u1ea1y Ti\u1ec1n M\u1eb7t V\u1eefng V\u00e0ng<\/strong>: 116,6 tri\u1ec7u USD t\u00e0i tr\u1ee3 ho\u1ea1t \u0111\u1ed9ng \u0111\u1ebfn n\u0103m 2027<\/li>\n<li><strong>Nhi\u1ec1u Ch\u1ea5t X\u00fac T\u00e1c<\/strong>: Ba ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng c\u00f3 d\u1eef li\u1ec7u \u0111\u1ecdc trong n\u0103m 2025<\/li>\n<li><strong>FDA Fast Track<\/strong>: CRB-701 \u0111\u00e3 c\u00f3 ch\u1ec9 \u0111\u1ecbnh cho ung th\u01b0 c\u1ed5 t\u1eed cung<\/li>\n<li><strong>Th\u1eddi \u0110i\u1ec3m Th\u1ecb Tr\u01b0\u1eddng<\/strong>: B\u00e9o ph\u00ec v\u00e0 ung th\u01b0 l\u00e0 c\u00e1c l\u0129nh v\u1ef1c n\u00f3ng nh\u1ea5t trong ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe<\/li>\n<li><strong>L\u00e3nh \u0110\u1ea1o Kinh Nghi\u1ec7m<\/strong>: CEO Yuval Cohen c\u00f3 th\u00e0nh t\u00edch m\u1ea1nh trong ng\u00e0nh<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0110\u1ea7u Nh\u1ecf<\/strong>: Ph\u00e2n b\u1ed5 kh\u00f4ng qu\u00e1 2-5% danh m\u1ee5c cho c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>Trung B\u00ecnh Gi\u00e1 \u0110\u00f4 La<\/strong>: X\u00e2y d\u1ef1ng v\u1ecb th\u1ebf d\u1ea7n d\u1ea7n tr\u01b0\u1edbc b\u00e1o c\u00e1o thu nh\u1eadp th\u00e1ng 11<\/li>\n<li><strong>\u0110\u1eb7t L\u1ec7nh C\u1eaft L\u1ed7<\/strong>: B\u1ea3o v\u1ec7 kh\u1ecfi th\u1ea5t b\u1ea1i th\u1ea3m kh\u1ed1c trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/li>\n<li><strong>Theo D\u00f5i C\u00e1c Ch\u1ea5t X\u00fac T\u00e1c<\/strong>: \u0110\u00e1nh d\u1ea5u l\u1ecbch cho ESMO 2025 (th\u00e1ng 10) v\u00e0 b\u00e1o c\u00e1o qu\u00fd 3 (th\u00e1ng 11)<\/li>\n<\/ol>\n<p><strong>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc c\u1ee7a ng\u01b0\u1eddi k\u1ef3 c\u1ef1u<\/strong>: &#8220;Giao d\u1ecbch CRBP gi\u1ed1ng nh\u01b0 xem phim y h\u1ecdc \u2014 99% l\u00e0 c\u00f4ng vi\u1ec7c ph\u00f2ng th\u00ed nghi\u1ec7m nh\u00e0m ch\u00e1n, 1% l\u00e0 nh\u1eefng kho\u1ea3nh kh\u1eafc ngh\u1eb9t th\u1edf quy\u1ebft \u0111\u1ecbnh t\u1ea5t c\u1ea3. Ch\u1ec9 c\u1ea7n \u0111\u1eebng qu\u00ean m\u00e1y kh\u1eed rung c\u1ea3m x\u00fac c\u1ee7a b\u1ea1n!&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn N\u1ec1n T\u1ea3ng Giao D\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o c\u00f3 truy c\u1eadp NASDAQ v\u00e0 ph\u00ed h\u1ee3p l\u00fd<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n Th\u00e0nh N\u1ea1p Ti\u1ec1n T\u00e0i Kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i c\u00f3 th\u1ec3 m\u1ea5t<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;CRBP&#8221;<\/td>\n<td>S\u1eed d\u1ee5ng m\u00e3 ch\u1ee9ng kho\u00e1n ch\u00ednh x\u00e1c c\u1ee7a Corbus Pharmaceuticals<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn Lo\u1ea1i L\u1ec7nh<\/td>\n<td>D\u00f9ng l\u1ec7nh gi\u1edbi h\u1ea1n \u0111\u1ec3 ki\u1ec3m so\u00e1t gi\u00e1 v\u00e0o trong c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem L\u1ea1i v\u00e0 X\u00e1c Nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra k\u1ef9 chi ti\u1ebft l\u1ec7nh tr\u01b0\u1edbc khi ho\u00e0n t\u1ea5t<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0110\u1eb7t C\u1ea3nh B\u00e1o Gi\u00e1<\/td>\n<td>Theo d\u00f5i c\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3\/kh\u00e1ng c\u1ef1 quan tr\u1ecdng<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>L\u1eadp K\u1ebf Ho\u1ea1ch R\u00fat L\u1eddi<\/td>\n<td>X\u00e1c \u0111\u1ecbnh tr\u01b0\u1edbc c\u00e1c m\u1ee9c ch\u1ed1t l\u1eddi v\u00e0 c\u1eaft l\u1ed7<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Ghi L\u1ea1i L\u00fd Do \u0110\u1ea7u T\u01b0<\/td>\n<td>Vi\u1ebft ra l\u00fd do \u0111\u1ea7u t\u01b0 \u0111\u1ec3 tr\u00e1nh quy\u1ebft \u0111\u1ecbnh theo c\u1ea3m x\u00fac<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>Theo D\u00f5i Tin T\u1ee9c C\u00f4ng Ty<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o Google cho c\u00e1c c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng c\u1ee7a CRBP<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>\u0110\u00e1nh Gi\u00e1 \u0110\u1ecbnh K\u1ef3<\/td>\n<td>\u0110\u00e1nh gi\u00e1 l\u1ea1i kho\u1ea3n \u0111\u1ea7u t\u01b0 sau m\u1ed7i b\u00e1o c\u00e1o thu nh\u1eadp<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option N\u1ed5i B\u1eadt Trong \u0110\u1ea7u T\u01b0 C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2>\n<p>Pocket Option c\u00e1ch m\u1ea1ng h\u00f3a giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc v\u1edbi c\u00e1c t\u00ednh n\u0103ng ph\u00f9 h\u1ee3p ho\u00e0n h\u1ea3o cho c\u00e1c c\u1ed5 phi\u1ebfu bi\u1ebfn \u0111\u1ed9ng nh\u01b0 CRBP:<\/p>\n<ul>\n<li><strong>S\u1ed1 Ti\u1ec1n N\u1ea1p T\u1ed1i Thi\u1ec3u Ch\u1ec9 5 USD<\/strong> &#8211; Th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c v\u1edbi ti\u1ec1n th\u1eadt m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn<\/li>\n<li><strong>Th\u1ef1c Thi Nhanh Nh\u01b0 Ch\u1edbp<\/strong> &#8211; Quan tr\u1ecdng \u0111\u1ec3 b\u1eaft k\u1ecbp c\u00e1c bi\u1ebfn \u0111\u1ed9ng do tin t\u1ee9c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<li><strong>C\u00f4ng C\u1ee5 Bi\u1ec3u \u0110\u1ed3 Ti\u00ean Ti\u1ebfn<\/strong> &#8211; Ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt \u0111\u1ec3 \u0111\u1ecbnh th\u1eddi \u0111i\u1ec3m v\u00e0o l\u1ec7nh quanh c\u00e1c ch\u1ea5t x\u00fac t\u00e1c l\u00e2m s\u00e0ng<\/li>\n<li><strong>Truy C\u1eadp Th\u1ecb Tr\u01b0\u1eddng To\u00e0n C\u1ea7u<\/strong> &#8211; Giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc M\u1ef9 t\u1eeb b\u1ea5t c\u1ee9 \u0111\u00e2u tr\u00ean th\u1ebf gi\u1edbi<\/li>\n<li><strong>T\u00e0i Nguy\u00ean Gi\u00e1o D\u1ee5c<\/strong> &#8211; H\u1ecdc \u0111\u1ea7u t\u01b0 c\u00f4ng ngh\u1ec7 sinh h\u1ecdc qua <a href=\"\/blog\">blog Pocket Option<\/a><\/li>\n<\/ul>\n<p>Giao di\u1ec7n th\u00e2n thi\u1ec7n c\u1ee7a n\u1ec1n t\u1ea3ng gi\u00fap ph\u00e2n t\u00edch c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ph\u1ee9c t\u1ea1p tr\u1edf n\u00ean d\u1ec5 ti\u1ebfp c\u1eadn v\u1edbi ng\u01b0\u1eddi m\u1edbi b\u1eaft \u0111\u1ea7u \u0111\u1ed3ng th\u1eddi cung c\u1ea5p c\u00f4ng c\u1ee5 n\u00e2ng cao cho nh\u00e0 giao d\u1ecbch c\u00f3 kinh nghi\u1ec7m.<\/p>\n<h2>\ud83c\udf0d Corbus N\u0103m 2025: \u0110\u1ed5i M\u1edbi Ung Th\u01b0 G\u1eb7p G\u1ee1 Khoa H\u1ecdc Chuy\u1ec3n H\u00f3a<\/h2>\n<p>Corbus Pharmaceuticals \u0111\u1ee9ng \u1edf tuy\u1ebfn \u0111\u1ea7u \u0111\u1ed5i m\u1edbi y h\u1ecdc v\u1edbi ba ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng \u0111\u1ed9t ph\u00e1:<\/p>\n<ul>\n<li><strong>CRB-701<\/strong> &#8211; Li\u00ean h\u1ee3p kh\u00e1ng th\u1ec3 &#8211; thu\u1ed1c nh\u1eafm m\u1ee5c ti\u00eau Nectin-4 cho th\u1ea5y k\u1ebft qu\u1ea3 s\u1edbm \u0111\u1ea7y h\u1ee9a h\u1eb9n trong c\u00e1c kh\u1ed1i u r\u1eafn. <a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/08\/05\/3127283\/0\/en\/Corbus-Pharmaceuticals-Reports-Second-Quarter-2025-Financial-Results-and-Provides-a-Corporate-Update.html\">Ch\u1ec9 \u0111\u1ecbnh FDA Fast Track<\/a> cho \u0111i\u1ec1u tr\u1ecb ung th\u01b0 c\u1ed5 t\u1eed cung nh\u1ea5n m\u1ea1nh ti\u1ec1m n\u0103ng c\u1ee7a n\u00f3.<\/li>\n<li><strong>CRB-913<\/strong> &#8211; Ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb b\u00e9o ph\u00ec th\u1ebf h\u1ec7 th\u1ee9 hai m\u1edbi tr\u00e1nh c\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 th\u1ea7n kinh \u0111\u00e3 l\u00e0m th\u1ea5t b\u1ea1i c\u00e1c ch\u1ea5t \u1ee9c ch\u1ebf CB1 tr\u01b0\u1edbc \u0111\u00f3. Nghi\u00ean c\u1ee9u giai \u0111o\u1ea1n 1 \u0111\u00e3 b\u1eaft \u0111\u1ea7u c\u00f3 th\u1ec3 khai th\u00e1c th\u1ecb tr\u01b0\u1eddng b\u00e9o ph\u00ec tr\u1ecb gi\u00e1 h\u01a1n 100 t\u1ef7 USD.<\/li>\n<li><strong>CRB-601<\/strong> &#8211; Li\u1ec7u ph\u00e1p ch\u1ed1ng integrin nh\u1eafm v\u00e0o nhi\u1ec1u lo\u1ea1i kh\u1ed1i u r\u1eafn, \u0111\u1ea1i di\u1ec7n cho c\u01a1 h\u1ed9i l\u00e2m s\u00e0ng l\u1edbn th\u1ee9 ba c\u1ee7a c\u00f4ng ty.<\/li>\n<\/ul>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: N\u0103m 2025, Corbus tr\u1edf th\u00e0nh m\u1ed9t trong s\u1ed1 \u00edt c\u00f4ng ty c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u1ed3ng th\u1eddi ti\u1ebfn h\u00e0nh ba ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng ri\u00eang bi\u1ec7t trong khi duy tr\u00ec ngu\u1ed3n ti\u1ec1n m\u1eb7t \u0111\u1ee7 d\u00f9ng \u0111\u1ebfn n\u0103m 2027 \u2014 m\u1ed9t th\u00e0nh t\u1ef1u \u0111\u00e1ng kinh ng\u1ea1c v\u1ec1 hi\u1ec7u qu\u1ea3 v\u1ed1n trong ng\u00e0nh d\u01b0\u1ee3c sinh h\u1ecdc v\u1ed1n ti\u00eau hao ti\u1ec1n m\u1eb7t r\u1ea5t l\u1edbn.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu CRBP th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 truy c\u1eadp NASDAQ. H\u00e3y ch\u1ecdn n\u1ec1n t\u1ea3ng ph\u00f9 h\u1ee3p, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu \"CRBP\", ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"CRBP c\u00f3 nh\u1eefng r\u1ee7i ro \u0111\u1ea7u t\u01b0 n\u00e0o?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m kh\u1ea3 n\u0103ng th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, ti\u00eau hao ti\u1ec1n m\u1eb7t, \u00e1p l\u1ef1c c\u1ea1nh tranh, kh\u00f4ng ch\u1eafc ch\u1eafn v\u1ec1 quy \u0111\u1ecbnh FDA v\u00e0 r\u1ee7i ro pha lo\u00e3ng c\u1ed5 phi\u1ebfu do g\u00e2y qu\u1ef9 trong t\u01b0\u01a1ng lai."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 c\u1ee7a CRBP trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o gi\u00e1 CRBP c\u00f3 th\u1ec3 t\u0103ng l\u00ean 18-25 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 30-45 USD n\u0103m 2026, 60-85 USD n\u0103m 2028 v\u00e0 tr\u00ean 100 USD v\u00e0o n\u0103m 2030, t\u00f9y thu\u1ed9c v\u00e0o k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng th\u00e0nh c\u00f4ng."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o CRBP?","answer":"Pocket Option cung c\u1ea5p s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, th\u1ef1c thi nhanh, c\u00f4ng c\u1ee5 bi\u1ec3u \u0111\u1ed3 ti\u00ean ti\u1ebfn, truy c\u1eadp th\u1ecb tr\u01b0\u1eddng to\u00e0n c\u1ea7u v\u00e0 t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c, r\u1ea5t ph\u00f9 h\u1ee3p cho giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 CRBP."},{"question":"Nh\u1eefng b\u01b0\u1edbc c\u01a1 b\u1ea3n \u0111\u1ec3 nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi b\u1eaft \u0111\u1ea7u v\u1edbi CRBP l\u00e0 g\u00ec?","answer":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf, \u00e1p d\u1ee5ng chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1 \u0111\u00f4 la, \u0111\u1eb7t l\u1ec7nh c\u1eaft l\u1ed7 \u0111\u1ec3 b\u1ea3o v\u1ec7, theo d\u00f5i c\u00e1c ch\u1ea5t x\u00fac t\u00e1c quan tr\u1ecdng v\u00e0 \u0111\u00e1nh gi\u00e1 l\u1ea1i \u0111\u1ea7u t\u01b0 \u0111\u1ecbnh k\u1ef3."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)?","answer":"B\u1ea1n c\u00f3 th\u1ec3 mua c\u1ed5 phi\u1ebfu CRBP th\u00f4ng qua c\u00e1c n\u1ec1n t\u1ea3ng giao d\u1ecbch ch\u1ee9ng kho\u00e1n c\u00f3 truy c\u1eadp NASDAQ. H\u00e3y ch\u1ecdn n\u1ec1n t\u1ea3ng ph\u00f9 h\u1ee3p, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu \"CRBP\", ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 x\u00e1c nh\u1eadn giao d\u1ecbch."},{"question":"CRBP c\u00f3 nh\u1eefng r\u1ee7i ro \u0111\u1ea7u t\u01b0 n\u00e0o?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m kh\u1ea3 n\u0103ng th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, ti\u00eau hao ti\u1ec1n m\u1eb7t, \u00e1p l\u1ef1c c\u1ea1nh tranh, kh\u00f4ng ch\u1eafc ch\u1eafn v\u1ec1 quy \u0111\u1ecbnh FDA v\u00e0 r\u1ee7i ro pha lo\u00e3ng c\u1ed5 phi\u1ebfu do g\u00e2y qu\u1ef9 trong t\u01b0\u01a1ng lai."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 c\u1ee7a CRBP trong t\u01b0\u01a1ng lai nh\u01b0 th\u1ebf n\u00e0o?","answer":"D\u1ef1 b\u00e1o gi\u00e1 CRBP c\u00f3 th\u1ec3 t\u0103ng l\u00ean 18-25 USD v\u00e0o cu\u1ed1i n\u0103m 2025, 30-45 USD n\u0103m 2026, 60-85 USD n\u0103m 2028 v\u00e0 tr\u00ean 100 USD v\u00e0o n\u0103m 2030, t\u00f9y thu\u1ed9c v\u00e0o k\u1ebft qu\u1ea3 l\u00e2m s\u00e0ng th\u00e0nh c\u00f4ng."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o CRBP?","answer":"Pocket Option cung c\u1ea5p s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, th\u1ef1c thi nhanh, c\u00f4ng c\u1ee5 bi\u1ec3u \u0111\u1ed3 ti\u00ean ti\u1ebfn, truy c\u1eadp th\u1ecb tr\u01b0\u1eddng to\u00e0n c\u1ea7u v\u00e0 t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c, r\u1ea5t ph\u00f9 h\u1ee3p cho giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 CRBP."},{"question":"Nh\u1eefng b\u01b0\u1edbc c\u01a1 b\u1ea3n \u0111\u1ec3 nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi b\u1eaft \u0111\u1ea7u v\u1edbi CRBP l\u00e0 g\u00ec?","answer":"Nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi n\u00ean b\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf, \u00e1p d\u1ee5ng chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1 \u0111\u00f4 la, \u0111\u1eb7t l\u1ec7nh c\u1eaft l\u1ed7 \u0111\u1ec3 b\u1ea3o v\u1ec7, theo d\u00f5i c\u00e1c ch\u1ea5t x\u00fac t\u00e1c quan tr\u1ecdng v\u00e0 \u0111\u00e1nh gi\u00e1 l\u1ea1i \u0111\u1ea7u t\u01b0 \u0111\u1ecbnh k\u1ef3."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-25T20:21:20+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)\",\"datePublished\":\"2025-08-25T20:21:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/\"},\"wordCount\":25,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"datePublished\":\"2025-08-25T20:21:20+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-25T20:21:20+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)","datePublished":"2025-08-25T20:21:20+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/"},"wordCount":25,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","datePublished":"2025-08-25T20:21:20+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals3.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Corbus Pharmaceuticals Holdings, Inc. (CRBP)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":351063,"slug":"how-to-buy-corbus-pharmaceuticals-holdings","post_title":"Como comprar a\u00e7\u00f5es da Corbus Pharmaceuticals Holdings, Inc. (CRBP) - Investimento em a\u00e7\u00f5es da Corbus Pharmaceuticals Holdings, Inc. (CRBP)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-corbus-pharmaceuticals-holdings\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/351067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=351067"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/351067\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334009"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=351067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=351067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=351067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}